0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

THE USE OF IODINE IN TOXIC GOITERS

FREDERICK S. WETHERELL, M.D.; WILLIAM A. GROAT, M.D.
JAMA. 1937;108(7):547-548. doi:10.1001/jama.1937.02780070031009.
Text Size: A A A
Published online

ABSTRACT

The feeling that there is a definite trend toward the use of iodine in the treatment of toxic thyroid disease prompts the present discussion. It is to be presumed that there has been no appreciable decrease in the number of cases of diffuse toxic goiter and of nodular toxic goiter during the past six or seven years, yet the number of patients who have been submitting to thyroidectomy has markedly decreased. Furthermore, many who finally come to surgery have suffered from their disease for a longer period than was the case a few years ago. Many of these individuals have been given iodine in one form or another as part of their treatment. In a considerable number of instances they not only have become poor surgical risks but have an increased morbidity element which lengthens both the preoperative and the convalescent period.

It has been pointed out many times in

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();